Login  

 

The article you requested is

Academic Highlights: Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Other Psychiatric Disorders. Part I: Unique Patient Populations

J Clin Psychiatry 1998;59(5):259-260
First page of Academic Highlights: Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Other Psychiatric Disorders. Part I: Unique Patient Populations

Click to enlarge page

A large proportion of patients with schizophrenia fail to respond adequately to their medications and can be considered as treatment-refractory, Dr. Stephen R. Marder declared. The advent of newer atypical antipsychotics requires an expanded definition of treatment refractoriness and more thoughtful application of treatment alternatives to the traditional dopamine receptor antagonists. In this context, Dr. Marder discussed positive symptoms and broadened the definition of patients who could be considered treatment- refractory.

mask